- Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis
-
Karashima R, Sagami S, Yamana Y, Maeda M, Hojo A, Miyatani Y, Nakano M, Matsuda T, Hibi T, Kobayashi T
- KMID: 2560297
- Intest Res.
- 2024 Oct;22(4):473-483.
- doi: 10.5217/ir.2023.00135
Background/Aims: Leucine-rich α-2-glycoprotein (LRG) is a new serum biomarker reflecting the disease activity of ulcerative colitis (UC), but its change during the acute phase has not been enough investigated. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
